Edition:
United States

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.21USD
4:00pm EDT
Change (% chg)

$0.16 (+3.95%)
Prev Close
$4.05
Open
$4.14
Day's High
$4.29
Day's Low
$4.09
Volume
15,281
Avg. Vol
9,293
52-wk High
$7.68
52-wk Low
$3.40

Chart for

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)

Overall

Beta: --
Market Cap(Mil.): $41.47
Shares Outstanding(Mil.): 10.55
Dividend: --
Yield (%): --

Financials

  ATXI.OQ Industry Sector
P/E (TTM): -- 29.21 33.15
EPS (TTM): -2.24 -- --
ROI: -2,494.21 13.66 13.23
ROE: -9,787.97 15.51 15.27

BRIEF-Avenue Therapeutics Reports Q4 Loss Per Share $0.63

* AVENUE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

Mar 01 2018

Earnings vs. Estimates